Pendapatan operasional sadurunge ngurangi amortisasi: Genetic Technologies (GENE)

Tandha merek gtglabs.com (GENE)

Genetic Technologies minimizes risks by developing diagnostics for predisposition to diabetes and oncology. The consolidated EBITDA demonstrates operational resilience, where the level captures the current state. This is supported by a streamlined international system for shipping biomaterials. Fundamental growth is constrained by strict FDA and CLIA oversight, as well as the existence of exclusive patents for predictive research.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi: gtglabs.com (GENE) kanggo 04.07.2022 - 10.11.2026

Genetic Technologies Limited (GENE) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:Genetic Technologies - GENE
Barang utama gtglabs.com

To identify stability drivers, an investor must analyze the operating cash flow before depreciation and interest, which reflects the business's actual ability to generate cash regardless of accounting adjustments. The consolidated EBITDA trend confirms the financial resilience of Genetic Technologies, converting its flawless reputation in precision genomics and physician trust into concrete cash equivalents.

Karo sapa Genetic Technologies saingan

Agilent Corp (A) - Bathi sadurunge bunga, pajak, lan amortisasi|DGX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi illumina.com ILMN|EXAS: Bathi operasional EBITDA|RVTY - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA SHC|quidel.com (QDEL) - Bathi operasional sadurunge potongan amortisasi|Bathi operasional EBITDA OPK (OPKO Health)|CareDx Corp (CDNA) - Bathi sadurunge bunga, pajak, lan amortisasi|MRVI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|FLGT (Fulgent) - Bathi operasional sadurunge amortisasi|LAB: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi cytekbio.com (CTKB)|Bathi operasional sadurunge ngurangi amortisasi OSUR|XGN (Exagen Diagnostics) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi operasional EBITDA MDXH|Pendapatan operasional sadurunge ngurangi amortisasi Lucid Diagnostics, Inc|Bathi operasional EBITDA PRE (Prenetics)|IMDX - Bathi operasional sadurunge ngurangi amortisasi|TRIB: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi PRPH (ProPhase Labs Inc)|AIMD (Ainos Corp) - Bathi operasional sadurunge ngurangi amortisasi|CODX: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|HSCS (Heart Test Laboratories) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi biomerica.com BMRA|Bathi operasional EBITDA CDIO|Bathi operasional sadurunge ngurangi amortisasi Onconetix Inc ONCO|Bathi operasional EBITDA VRAX (Virax Biolabs Group Ltd)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi BJDX|AWH - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|AXDX (acceleratediagnostics.com) - Bathi operasional sadurunge amortisasi|Centogene N.V. (CNTG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Enzo Biochem (ENZ)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Fresh2 Group Ltd|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ME|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Psychemedics (PMD)